Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study

English version České info

In a modeling study addressing measles vaccination approaches in four developing countries, Justin Lessler and colleagues investigate the relative merits of disease outbreak or serologically triggered vaccination campaigns.

Vyšlo v časopise: Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study. PLoS Med 13(10): e32767. doi:10.1371/journal.pmed.1002144
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1002144

Souhrn

Zdroje

1. World Health Organization. Progress towards regional measles elimination, worldwide, 2000–2014. Wkly Epidemiol Rec. 2015;90: 623–31. 26567399

2. World Health Organization. Global measles and rubella strategic plan: 2012–2020. Geneva: World Health Organization; 2012.

3. Cutts FT, Lessler J, Metcalf CJ. Measles elimination: progress, challenges and implications for rubella control. Expert Rev Vaccines. 2013;12: 917–32. doi: 10.1586/14760584.2013.814847 23984961

4. World Health Organization. Response to measles outbreaks in measles mortality reduction settings, Report No.: WHO/IVB/09.03. Geneva: World Health Organization; 2009.

5. Grais RF, De Radiguès X, Dubray C, Fermon F, Guerin PJ. Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect. 2006;134: 845–9. doi: 10.1017/S0950268805005716 16438743

6. Grais RF, Conlan AJK, Ferrari MJ, Djibo A, Le Menach A, Bjørnstad ON, et al. Time is of the essence: exploring a measles outbreak response vaccination in Niamey, Niger. J R Soc Interface. 2008;5: 67–74. doi: 10.1098/rsif.2007.1038 17504737

7. Cairns KL, Perry RT, Ryman TK, Nandy RK, Grais RF. Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update. J Infect Dis. 2011;204 Suppl: S35–46. doi: 10.1093/infdis/jir072

8. Luquero FJ, Pham-Orsetti H, Cummings DA, Ngaunji PE, Nimpa M, Fermon F, et al. A long-lasting measles epidemic in Maroua, Cameroon 2008–2009: mass vaccination as response to the epidemic. J Infect Dis. 2011;204 Suppl: S243–51. doi: 10.1093/infdis/jir093

9. Pan American Health Organization. Measles elimination: field guide. Washington D.C.: PAHO; 2005.

10. Goodson JL, Chu SY, Rota PA, Moss WJ, Featherstone DA, Vijayaraghavan M, et al. Research priorities for global measles and rubella control and eradication. Vaccine. 2012;30: 4709–16. doi: 10.1016/j.vaccine.2012.04.058 22549089

11. Bauch CT, Szusz E, Garrison LP. Scheduling of measles vaccination in low-income countries: projections of a dynamic model. Vaccine. 2009;27: 4090–8. doi: 10.1016/j.vaccine.2009.04.079 19410622

12. Ferrari MJ, Grais RF, Bharti N, Conlan AJK, Bjørnstad ON, Wolfson LJ, et al. The dynamics of measles in sub-Saharan Africa. Nature. 2008;451: 679–84. doi: 10.1038/nature06509 18256664

13. Drake JM. Limits to forecasting precision for outbreaks of directly transmitted diseases. PLoS Med. 2006;3: e3. doi: 10.1371/journal.pmed.0030003 16435887

14. Klepac P, Bjørnstad ON, Metcalf CJE, Grenfell BT. Optimizing reactive responses to outbreaks of immunizing infections: balancing case management and vaccination. PLoS ONE. 2012;7: e41428. doi: 10.1371/journal.pone.0041428 22899996

15. Miller E. The new measles campaign. BMJ. 1994;309: 1102–3. 7987096

16. Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev. 1994;4: R141–6. 7529089

17. Lessler J, Metcalf CJE, Grais RF, Luquero FJ, Cummings DA, Grenfell BT. Measuring the Performance of Vaccination Programs Using Cross-Sectional Surveys: A Likelihood Framework and Retrospective Analysis. PLoS Med. 2011;8: e1001110. doi: 10.1371/journal.pmed.1001110 22039353

18. Minetti A, Kagoli M, Katsulukuta A, Huerga H, Featherstone A, Chiotcha H, et al. Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi. Emerg Infect Dis. 2013;19: 202–9. doi: 10.3201/eid1902.120301 23343504

19. Lessler J, Moss WJ, Lowther SA, Cummings DAT. Maintaining high rates of measles immunization in Africa. Epidemiol Infect. 2010; 1–11. doi: 10.1017/S0950268810002232

20. Metcalf CJE, Lessler J, Klepac P, Cutts F, Grenfell BT. Impact of birth rate, seasonality and transmission rate on minimum levels of coverage needed for rubella vaccination. Epidemiol Infect. 2012; 1–12. doi: 10.1017/S0950268812000131

21. Ferrari MJ, Grenfell BT, Strebel PM. Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci. 2013;368: 20120141. doi: 10.1098/rstb.2012.0141 23798689

22. Guris D, Harpaz R, Redd SB, Smith NJ, Papania MJ. Measles surveillance in the United States: an overview. J Infect Dis. 2004;189 Suppl: S177–84. doi: 10.1086/374606

23. Burke DS, Gaydos JC, Hodder RA, Bancroft WH. Seroimmunity to polioviruses in U.S. Army recruits. J Infect Dis. 1979;139: 225–7. 220335